- Home
- UGRO vs ACXP Comparison
UGRO vs ACXP Comparison
Compare UGRO & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UGRO
- ACXP
- Stock Information
- Founded
- UGRO 2014
- ACXP 2017
- Country
- UGRO United States
- ACXP United States
- Employees
- UGRO N/A
- ACXP N/A
- Industry
- UGRO Industrial Specialties
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- UGRO Consumer Discretionary
- ACXP Health Care
- Exchange
- UGRO Nasdaq
- ACXP Nasdaq
- Market Cap
- UGRO 7.7M
- ACXP 8.4M
- IPO Year
- UGRO N/A
- ACXP 2021
- Fundamental
- Price
- UGRO $0.41
- ACXP $0.38
- Analyst Decision
- UGRO Strong Buy
- ACXP Strong Buy
- Analyst Count
- UGRO 1
- ACXP 1
- Target Price
- UGRO $3.00
- ACXP $12.00
- AVG Volume (30 Days)
- UGRO 373.7K
- ACXP 107.1K
- Earning Date
- UGRO 05-20-2025
- ACXP 05-13-2025
- Dividend Yield
- UGRO N/A
- ACXP N/A
- EPS Growth
- UGRO N/A
- ACXP N/A
- EPS
- UGRO N/A
- ACXP N/A
- Revenue
- UGRO $59,985,133.00
- ACXP N/A
- Revenue This Year
- UGRO N/A
- ACXP N/A
- Revenue Next Year
- UGRO $31.25
- ACXP N/A
- P/E Ratio
- UGRO N/A
- ACXP N/A
- Revenue Growth
- UGRO N/A
- ACXP N/A
- 52 Week Low
- UGRO $0.37
- ACXP $0.30
- 52 Week High
- UGRO $2.16
- ACXP $3.33
- Technical
- Relative Strength Index (RSI)
- UGRO 39.96
- ACXP 44.94
- Support Level
- UGRO $0.39
- ACXP $0.34
- Resistance Level
- UGRO $0.49
- ACXP $0.44
- Average True Range (ATR)
- UGRO 0.06
- ACXP 0.02
- MACD
- UGRO -0.00
- ACXP 0.00
- Stochastic Oscillator
- UGRO 11.98
- ACXP 37.35
About UGRO urban-gro Inc.
Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.